Hong Liu‐Seifert

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow et al. · New England Journal of Medicine · 2014 · 1.6K citations · Full text

Medicine, Neurology, Neuroscience +14

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Lawrence S. Honig, Bruno Vellas, Merçé Boada et al. · New England Journal of Medicine · 2018 · 1K citations · Full text

Medicine, Neurology, Pharmacology +17

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Eric Siemers, Karen Sundell, Christopher Carlson et al. · Alzheimer s & Dementia · 2015 · 365 citations · Full text

Medicine, Neurology, Pharmacotherapy +17

Duloxetine, a centrally acting analgesic, in the treatment of patients with osteoarthritis knee pain: A 13-week, randomized, placebo-controlled trial

Amy S. Chappell, Melissa J. Ossanna, Hong Liu‐Seifert et al. · Pain · 2009 · 300 citations

Medicine, Pharmacology, Pharmacotherapy +17

A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naïve patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial

Philip J. Mease, Josef S Smolen, Frank Behrens et al. · Annals of the Rheumatic Diseases · 2019 · 288 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15